Featured Research

from universities, journals, and other organizations

Scientists uncover protein that thwarts tumor invasion

Date:
June 9, 2010
Source:
UT Southwestern Medical Center
Summary:
Researchers have determined that cancer cells lacking a key protein are more invasive and more likely to metastasize, providing a possible drug target to combat certain tumor types.

Dr. Xicheng Mao (left) and Dr. Ezra Burstein.
Credit: Image courtesy of UT Southwestern Medical Center

Researchers at UT Southwestern Medical Center have determined that cancer cells lacking a key protein are more invasive and more likely to metastasize, providing a possible drug target to combat certain tumor types.

"Further down the line we could create a drug that would bring COMMD1 protein levels back to normal, or even above normal, in the tumor to hopefully affect cancer cell invasion," said Dr. Ezra Burstein, assistant professor of internal medicine and molecular biology and senior author of the study appearing in the June issue of the Journal of Clinical Investigation. "If the cancer cells have already started invading other organs, maybe further invasion would be halted or even regressed."

Dr. Burstein is a member of a research team that years ago discovered the COMMD family of proteins and its abilities. They discovered that one of those proteins, COMMD1, inhibits NF-kB, a key factor that activates genes involved in inflammation and that is often involved in helping cancer cells survive. COMMD1 also regulates a protein called HIF, which plays a role in the survival of cells in areas of low oxygen, a common feature of cancer. For example, enhanced HIF activity is associated with tumor growth, metastasis and poor clinical outcomes for cancer patients.

Because COMMD1 has this dual role in regulating both NF-kB and HIF, the researchers thought that COMMD1 might be inactivated or repressed in tumors. This study supports their hypothesis, as the scientists found decreased amounts of this protein in a variety of human cancers and the decreased expression of COMMD1 also was associated with more invasive cancers.

COMMD1 suppression in cancer cells leads to enhanced activity of both NF-kB and HIF, a one-two punch that makes the cancer more invasive, Dr. Burstein said.

In a review of 63 patients with endometrial cancer, the researchers determined that those whose tumors had the lowest levels of COMMD1 had the worst clinical outcomes.

Using mice, it was also discovered that the COMMD1-deficient cells were more invasive when implanted. The researchers then generated mouse melanoma cells that produced an overabundance of COMMD1, and injected those cells back into healthy mice. The number of metastatic lung tumors that resulted was greatly reduced when the cells expressed greater levels of COMMD1.

These results indicate that COMMD1 restrains the metastatic potential of an invasive cancer cell line, Dr. Burstein said.

"This is the first study that clearly links COMMD1 to human disease and substantiates what we would've expected based on the prior work we have done on this protein," he said. "COMMD1 is yet another player in the very important and complicated cancer invasion process."

The next step, Dr. Burstein said, will be to investigate what changes in the tumor environment may be responsible for reducing levels of COMMD1 in cancer cells.

Dr. Xicheng Mao, instructor in internal medicine at UT Southwestern, was a co-first author. Researchers at the University of Michigan Medical School, at University Medical Center Utrecht, University Medical Center Groningen, and Maastricht University Medical Centre in the Netherlands also participated in the study.

The study was funded by UT Southwestern's DOCS (Disease-Oriented Clinical Scholars) Program; Dutch Cancer Society; AEGON International Scholarship in Oncology; Netherlands Organization for Scientific Research; the Maurits Anna de Kock Foundation; and the Nijbakker -Morra Foundation.


Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Bart van de Sluis, Xicheng Mao, Yali Zhai, Arjan J. Groot, Jeroen F. Vermeulen, Elsken van der Wall, Paul J. van Diest, Marten H. Hofker, Cisca Wijmenga, Leo W. Klomp, Kathleen R. Cho, Eric R. Fearon, Marc Vooijs, Ezra Burstein. COMMD1 disrupts HIF-1α/β dimerization and inhibits human tumor cell invasion. Journal of Clinical Investigation, 2010; DOI: 10.1172/JCI40583

Cite This Page:

UT Southwestern Medical Center. "Scientists uncover protein that thwarts tumor invasion." ScienceDaily. ScienceDaily, 9 June 2010. <www.sciencedaily.com/releases/2010/06/100607101802.htm>.
UT Southwestern Medical Center. (2010, June 9). Scientists uncover protein that thwarts tumor invasion. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/2010/06/100607101802.htm
UT Southwestern Medical Center. "Scientists uncover protein that thwarts tumor invasion." ScienceDaily. www.sciencedaily.com/releases/2010/06/100607101802.htm (accessed August 1, 2014).

Share This




More Health & Medicine News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Quintuplets Head Home

Texas Quintuplets Head Home

Reuters - US Online Video (Aug. 1, 2014) After four months in the hospital, the first quintuplets to be born at Baylor University Medical Center head home. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Patient Coming to U.S. for Treatment

Ebola Patient Coming to U.S. for Treatment

Reuters - US Online Video (Aug. 1, 2014) A U.S. aid worker infected with Ebola while working in West Africa will be treated in a high security ward at Emory University in Atlanta. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Vaccine Might Be Coming, But Where's It Been?

Ebola Vaccine Might Be Coming, But Where's It Been?

Newsy (Aug. 1, 2014) Health officials are working to fast-track a vaccine — the West-African Ebola outbreak has killed more than 700. But why didn't we already have one? Video provided by Newsy
Powered by NewsLook.com
Study Links Certain Birth Control Pills To Breast Cancer

Study Links Certain Birth Control Pills To Breast Cancer

Newsy (Aug. 1, 2014) Previous studies have made the link between birth control and breast cancer, but the latest makes the link to high-estrogen oral contraceptives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins